Michael Wood
Host, LifeSite Advisors
Replay available
Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) Q4 2025 earnings conference call, held 2026-03-20. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Joseph Oliveto
President and Chief Executive Officer
Lorenz Muller
Chief Commercial Officer
Amit Hazija
Chief Financial Officer and EVP of Corporate Development
Athena Chin
Analyst, TD Cowan
Ted Tenthoff
Analyst, Piper Sandler
Brandon Folks
Analyst, HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Milestone Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.576 Good morning, ladies and gentlemen, and welcome to the Milestone Pharmaceuticals fourth 00:00:03.576 -- 00:00:07.742 quarter and year-end 2025 corporate update conference call. 00:00:07.742 -- 00:00:10.866 At this time, all participants are in listen-only mode. 00:00:10.866 -- 00:00:13.690 After the speaker's remarks, there will be a question-and-answer session. 00:00:13.690 -- 00:00:17.375 As a reminder, this conference is being recorded. 00:00:17.375 -- 00:00:21.261 I will now turn the call over to your host, Michael Wood of LifeSite Advisors. 00:00:21.261 -- 00:00:23.902 You may now begin your conference. 00:00:24.465 -- 00:00:26.812 Thank you, Operator. Good morning. Good morning, everyone. 00:00:26.812 -- 00:00:32.218 and welcome to the Milestone Pharmaceuticals full year 2025 financial 00:00:32.218 -- 00:00:35.602 results and business update conference call. 00:00:35.602 -- 00:00:38.645 Earlier this morning, the company issued a press release providing an overview of its 00:00:38.645 -- 00:00:44.131 financial results for the year ended December 31, 2025, and recent 00:00:44.131 -- 00:00:48.516 corporate highlights. The release can be accessed on the investors' media section of 00:00:48.516 -- 00:00:51.777 the company's website, milestonepharma.com. 00:00:51.938 -- 00:00:56.163 Before I begin, I'd like to remind everyone that some of the information presented on 00:00:56.163 -- 00:01:01.430 this conference call contains forward-looking statements under the securities laws. 00:01:01.430 -- 00:01:05.235 These forward-looking statements involve substantial risks and uncertainties that could 00:01:05.235 -- 00:01:10.622 cause actual clinical programs, future results, progress, timing, performances, 00:01:10.622 -- 00:01:15.988 or ...